Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial
Statistical Methods in Medical Research · 2023
DOI: 10.1177/09622802231160554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2023. Verfasst von Benjamin Duputel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universitè Paris Citè, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, Association Nationale de la Recherche et de la Technologie.
Abstract (Originalsprache)
Master protocol designs allow for simultaneous comparison of multiple treatments or disease subgroups. Master protocols can also be designed as seamless studies, in which two or more clinical phases are considered within the same trial. They can be divided into two categories: operationally seamless, in which the two phases are separated into two independent studies, and inferentially seamless, in which the interim analysis is considered an adaptation of the study. Bayesian designs are scarcely studied. Our aim is to propose and compare Bayesian operationally seamless Phase II/III designs using a binary endpoint for the first stage and a time-to-event endpoint for the second stage. At the end of Phase II, arm selection is based on posterior (futility) and predictive (selection) probabilities. The results of the first phase are then incorporated into prior distributions of a time-to-event model. Simulation studies showed that Bayesian operationally seamless designs can approach the inferentially seamless counterpart, allowing for an increasing simulated power with respect to the operationally frequentist design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universitè Paris Citè, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France.
- Inria, HeKA, Paris, France.
- eXYSTAT, Malakoff, France.
- Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
- Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debrè, Paris, France.
ORCID-Profile: Benjamin Duputel, François Montestruc, Sarah Zohar, Moreno Ursino
Förderung
- Medical Research Council
- Association Nationale de la Recherche et de la Technologie
Zitieren
APA
Duputel, B., Stallard, N., Montestruc, F., Zohar, S., & Ursino, M. (2023). Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802231160554
Vancouver
Duputel B, Stallard N, Montestruc F, Zohar S, Ursino M. Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial. Statistical Methods in Medical Research. 2023. doi:10.1177/09622802231160554
BibTeX
@article{Duputel2023,
author = {Duputel, Benjamin and Stallard, Nigel and Montestruc, François and Zohar, Sarah and Ursino, Moreno},
title = {Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial},
journal = {Statistical Methods in Medical Research},
year = {2023},
doi = {10.1177/09622802231160554}
}
EUVIMED